Rei Tsang Shiao

Array ( [id] => 8664464 [patent_doc_number] => 08377926 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => 'Aminopyridine kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 13/020947 [patent_app_country] => US [patent_app_date] => 2011-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25481 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13020947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9099732 [patent_doc_number] => 08563610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-22 [patent_title] => 'Polyunsaturated fatty acids interactions and oxidative stress disorders' [patent_app_type] => utility [patent_app_number] => 13/021196 [patent_app_country] => US [patent_app_date] => 2011-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2557 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13021196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8875346 [patent_doc_number] => 08470303 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-25 [patent_title] => 'Automated method and system for introducing molecular iodine into drinking water' [patent_app_type] => utility [patent_app_number] => 13/018955 [patent_app_country] => US [patent_app_date] => 2011-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4716 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13018955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8780615 [patent_doc_number] => 20130102591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => 'COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF PULMONARY HYPERTENSION' [patent_app_type] => utility [patent_app_number] => 13/575388 [patent_app_country] => US [patent_app_date] => 2011-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13731 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9281379 [patent_doc_number] => 20140031347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-30 [patent_title] => '1,2,4-OXADIAZOLE DERIVATIVES AS DRUGS MODULATING THE GLP-1 PEPTIDE RECEPTOR' [patent_app_type] => utility [patent_app_number] => 13/981554 [patent_app_country] => US [patent_app_date] => 2011-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6208 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13981554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10001602 [patent_doc_number] => 09045681 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-02 [patent_title] => 'Reduced drying carrier formulation' [patent_app_type] => utility [patent_app_number] => 13/980463 [patent_app_country] => US [patent_app_date] => 2011-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 8041 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13980463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055694 [patent_doc_number] => 20110112054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Organophosphorous Compounds for the Activation of Gamma/Delta T Cells' [patent_app_type] => utility [patent_app_number] => 13/007852 [patent_app_country] => US [patent_app_date] => 2011-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5893 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112054.pdf [firstpage_image] =>[orig_patent_app_number] => 13007852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8228576 [patent_doc_number] => 20120142748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'NOVEL CANNABINOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR THEIR PREPARATION' [patent_app_type] => utility [patent_app_number] => 13/006560 [patent_app_country] => US [patent_app_date] => 2011-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 83344 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13006560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650863 [patent_doc_number] => 20110300132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => '4-AMINOQUINAZOLINE PRODRUGS' [patent_app_type] => utility [patent_app_number] => 12/986135 [patent_app_country] => US [patent_app_date] => 2011-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9903 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300132.pdf [firstpage_image] =>[orig_patent_app_number] => 12986135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5984659 [patent_doc_number] => 20110097350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'METHODS EMPLOYING AND COMPOSITIONS CONTAINING DEFINED OXIDIZED PHOSPHOLIPIDS FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS' [patent_app_type] => utility [patent_app_number] => 12/985365 [patent_app_country] => US [patent_app_date] => 2011-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19477 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20110097350.pdf [firstpage_image] =>[orig_patent_app_number] => 12985365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8721315 [patent_doc_number] => 20130072533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-21 [patent_title] => 'COMPOUNDS WITH BOTH ANALGESIC AND ANTI-HYPERALGESIC EFFICACY' [patent_app_type] => utility [patent_app_number] => 13/520397 [patent_app_country] => US [patent_app_date] => 2011-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3197 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8653239 [patent_doc_number] => 08372988 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'Crystalline forms of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine' [patent_app_type] => utility [patent_app_number] => 12/982775 [patent_app_country] => US [patent_app_date] => 2010-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8564 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12982775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8560249 [patent_doc_number] => 08334313 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-18 [patent_title] => 'Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease' [patent_app_type] => utility [patent_app_number] => 12/980495 [patent_app_country] => US [patent_app_date] => 2010-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34185 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12980495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8713347 [patent_doc_number] => 08399487 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Pyrazole compounds and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/975862 [patent_app_country] => US [patent_app_date] => 2010-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 27255 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12975862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8713545 [patent_doc_number] => 08399686 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Process for preparing cyclic esters comprising unsaturated functional groups and polyesters prepared from same' [patent_app_type] => utility [patent_app_number] => 12/968820 [patent_app_country] => US [patent_app_date] => 2010-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8678 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12968820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8328880 [patent_doc_number] => 08236966 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-07 [patent_title] => 'Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, alpha-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid' [patent_app_type] => utility [patent_app_number] => 12/966488 [patent_app_country] => US [patent_app_date] => 2010-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 15652 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12966488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9427674 [patent_doc_number] => 08703749 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Compositions and methods for treating Friedreich\'s Ataxia' [patent_app_type] => utility [patent_app_number] => 13/514288 [patent_app_country] => US [patent_app_date] => 2010-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 9 [patent_no_of_words] => 12374 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13514288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8660140 [patent_doc_number] => 20130040970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'Co-Crystals Of A Triazolo [4,5-D] Pyrimide Platelet Aggregation Inhibitor' [patent_app_type] => utility [patent_app_number] => 13/513482 [patent_app_country] => US [patent_app_date] => 2010-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9773 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13513482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663742 [patent_doc_number] => 20110313011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'Amino Acid Compounds' [patent_app_type] => utility [patent_app_number] => 12/946114 [patent_app_country] => US [patent_app_date] => 2010-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7898 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20110313011.pdf [firstpage_image] =>[orig_patent_app_number] => 12946114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663743 [patent_doc_number] => 20110313012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'Amino Acid Compounds' [patent_app_type] => utility [patent_app_number] => 12/946153 [patent_app_country] => US [patent_app_date] => 2010-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7944 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20110313012.pdf [firstpage_image] =>[orig_patent_app_number] => 12946153 [rel_patent_id] =>[rel_patent_doc_number] =>)